Athens-based VC firms Big Pi Ventures and Evercurious VC have invested $4.5M in ORamaVR, the startup pioneering Computational Medical Extended Reality platform. With their solutions being used by ...

Optimism was high at the launch events for Swiss Venture Capital Report. However, it was also clear that further success will not happen automatically.

In the second half of 2025 five medtech and digital health startups obtained the Innosuisse Certificate, a readiness label for startups positioned for sustainable growth. Their products range from ...

EPFL spinoff Aesyra has completed the clinical investigation evaluating the efficacy and safety of its flagship product, AesyBite™ Active. The intelligent oral device combines a customized oral ...

The third cohort of the Microsoft for Startups Switzerland AI Tech Accelerator comprises 11 startups building AI-powered solutions across a wide range of industries. From February 2 to mid-April 2026, ...

The much-cited term ‘ecosystem’ means, not least, that all players in the start-up sector must grow together. That is why the simultaneous development of start-ups, investors and support organisations ...

The ESA BIC Switzerland organization committee has onboarded a new cohort of six startups joining the 2026 edition. ESA BIC Switzerland supports Swiss startups that leverage space technologies for ...

Philanthropic initiative Venture Kick provides up to CHF 150,000 seed funding to Swiss startups and offers a well-structured entrepreneurial path toward building a winning business. Startups pitch to ...

Xer Tech has obtained an operational approval for flights Beyond Visual Line of Sight (BVLOS) with Xer Tech’s X8 drone in Switzerland and in Hungary. The approval opens a gateway to commercialize the ...

The freshly launched Relativity Collective is a highly selective pan-European student network for the next generation of founders. At the core of this initiative is the belief that Europe produces ...

Virometix has revealed encouraging Phase 1 data for their lead vaccine asset, V-212, a synthetic vaccine designed to prevent pneumococcal disease caused by Streptococcus pneumoniae. In parallel, ...

With team.blue as strategic partner alongside the existing shareholders, Windsor.ai’s current management team will continue to lead day-to-day operations and drive the company’s next phase of growth.